-+ 0.00%
-+ 0.00%
-+ 0.00%

HC Wainwright & Co. Maintains Buy on Regenxbio, Lowers Price Target to $26

Benzinga·06/05/2026 17:42:37
Listen to the news
HC Wainwright & Co. analyst Yi Chen maintains Regenxbio (NASDAQ:RGNX) with a Buy and lowers the price target from $30 to $26.